Stocks To Watch On 15 June: Vedanta, Meesho, JSW Energy and More

Indian equity markets ended Friday on a strong note, recording their best single-day gain in nearly two months. The BSE Sensex surged 1,695 points, or 2.3%, to close at 75,528, while the NSE Nifty 50 climbed 461 points, or 1.99%, to settle at 23,623.

Here are some of the stocks that are expected to remain in focus on 15 June following key corporate announcements, operational updates and regulatory developments.

Stocks In Focus

Vedanta

All four demerged Vedanta entities, namely Vedanta Aluminium, Vedanta Oil & Gas, Vedanta Power, and Vedanta Iron & Steel, are set to commence trading on the stock exchanges on 15 June. Investors will be closely watching the aluminium business as the group moves ahead with its restructuring plans.

Meesho

Meesho has announced the acquisition of Kirana Club Pte. Ltd and Retail Pulse Labs Private Ltd for a total consideration of ₹202.08 crore.

Ipca Laboratories

Ipca Laboratories has signed a global licensing agreement with Bhami's Research Laboratory. The deal gives Ipca access to BRL's proprietary high-concentration subcutaneous biologics delivery platform.

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories has launched Bosutinib Tablets in the United States for the treatment of chronic myeloid leukaemia (CML). The 400 mg tablets are a generic equivalent of Bosulif and expand the company's oncology portfolio in the US market.

JSW Energy

JSW Energy announced that its wholly owned subsidiary, JSW Neo Energy, has commissioned the remaining 150 MW capacity of the Tidong Hydroelectric Project in Himachal Pradesh.

HPCL

Hindustan Petroleum Corporation (HPCL) has fixed 14 August 2026 as the record date for determining shareholder eligibility for its proposed final dividend of ₹19.25 per equity share for FY26. The dividend remains subject to shareholder approval at the forthcoming Annual General Meeting (AGM).

Power Grid

Power Grid Corporation of India has been declared the successful bidder for an inter-state transmission system project in Andhra Pradesh under the tariff-based competitive bidding (TBCB) framework.

Aurobindo Pharma

The US Food and Drug Administration (FDA) has classified the inspection of Eugia Pharma Specialities' Unit-III facility as "Official Action Indicated" (OAI).

ONGC

ONGC's subsidiary, ONGC Petro Additions Ltd (OPaL), has approved a fund-raising plan. The company may raise up to ₹4,471 crore through a private placement of non-convertible debentures (NCDs).

Also Read- Pre-Market 15 June 2026

Sources

Reuters

CNBC TV18